07

Dr. Heather Greenlee discussed a new study on anti-inflammatory diets and colorectal cancer. She said, “The issue that a lot of patients face is that people don’t know how to make these dietary changes that are sustainable over time.”

Dr. Stacey Cohen discussed tumor DNA tests: “Research is trying to keep up with the pace of clinical use. It’s a really exciting technology, but it’s difficult to interpret and actually use [the] test result.”

Dr. Hans-Peter Kiem described his research on gene therapies: “That gets me up every morning, to be honest, to be able to think about how can we really manufacture these treatments to help patients whether it's genetic diseases or cancer.”

Dr. Steve Pergam noted that federal advisory committees that evaluate vaccines “are the envy of most countries in how we address these policies and how we’ve done this. These are people that have spent their lives working on vaccines.”

Dr. Britney Barber discussed jaw cancer risk factors: “Tobacco and alcohol use are both well-established risk factors. Together, they’re a dangerous combination, boosting your risk at least 15 times above normal.”

Dr. Trevor Bedford explained aspects of a new COVID variant: “There's going to be some correlation between the new variants and worse infections, but it's probably not the case that it's due to some intrinsic biological difference.”

The Cancer Letter covered the appointment of Seattle leaders Ric Anderson and Eduardo Peñalver to chair and vice chair of the Board of Directors, as well as Jim Lico joining the board as a new member.